Advertisement
Financing › Details
Qtis/e–Xeltis: investment, 2012 merger of Qtis/e with Xeltis
Period | 2012-01-01 | |
Money taker | Qtis/e (NL) | |
Today | Xeltis B.V. | |
Group | Xeltis (Group) | |
Money source | Xeltis AG | |
Group | Xeltis (Group) | |
Product | valve (medical) | |
Product 2 | MedTech (medical technology) | |
Record changed: 2018-01-02 |
Advertisement
More documents for Xeltis (Group)
- [1] Xeltis AG. (11/15/17). "Press Release: Xeltis Closes €45 Million in Oversubscribed Series C Financing to Advance Aortic and Pulmonary Valve Programs". Zurich & Eindhoven....
- [2] Xeltis AG. (1/31/17). "Press Release: FDA Gives Xeltis Go Ahead to Begin Trials in the USA"....
To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement
» top